arrow
T

Thomas H. Carter

royal marsden nhs foundation trust
H指数:30
被引数:4,517

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

INVESTIGATING SHORT TERM (<6 MONTHS) SURVIVORS OF GLIOBLASTOMA - AN ANALYSIS OF THE HISTO-MOL GBM COLLABORATIVE DATABASE.

调查短期(<6个月)胶质母细胞瘤生存者——基于Histology-Molecular GBM Collaborative数据库的分析。

2025-10-010
OAAI
GLIOBLASTOMA IN OLDER ADULTS, A NEED FOR BOLDER TREATMENT IN SELECTED PATIENTS?
2024-10-170
PRE
Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia

促血管生成因子EGFL7在急性髓系白血病中的预后和生物学意义

2017-05-2235
OAAI
Expression and prognostic impact of lncRNAs in acute myeloid leukemia

lncRNAs在急性髓系白血病中的表达及预后影响

2014-12-15214
OAAI
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia
LEUKEMIA
IF13.4
2014-09-1067
OAAI
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8
LEUKEMIA
IF13.4
2014-03-2124
OAAI
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy

GAS6表达鉴定高危成人AML患者: 治疗的潜在意义

LEUKEMIA
IF13.4
2013-12-1148
OAAI
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia
LEUKEMIA
IF13.4
2013-06-1452
OAAI
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline

在罕见的同时携带RUNX1和NPM1突变的急性髓系白血病患者中,RUNX1突变在结构上是不寻常的,并且存在于种系中

2013-06-109
OAAI